Company intelligence / Profile preview

Opentrons Labworks

Brooklyn, New York, United States

Ownership: Private
Employees: ~268
Development stage: Other

Overview

Opentrons manufactures flexible, user-friendly liquid handling lab robots used for automating research and diagnostic workflows. The company operates as a market leader in entry-level lab automation, serving thousands of academic, biopharma, synthetic biology, and clinical research institutions across more than 40 countries. Their robots have demonstrated significant impact, including COVID-19 testing acceleration from 7-14 days to 12 hours with cost reduction from $2,000 to under $28.

Modalities: Device
Industry: Non-Drug Biotech

Partnerships

MilliporeSigma (Merck)NYU Langone HealthMayo ClinicHarvardStanfordCaltechMITBioNTech

Beyond the preview

Go deeper on Opentrons Labworks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opentrons Labworks.

Explore the full profile